Home › Atopic Dermatitis (Eczema) › California › Los Angeles
Atopic Dermatitis (Eczema) clinical trials in Los Angeles, CA
11 studies for Atopic Dermatitis (Eczema) are looking for participants at sites in and around Los Angeles (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
RecruitingObservational study
- Dermatology Research Associates - Los Angeles- Site Number : 8400020, Los Angeles
Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis
RecruitingPhase 2
- Novartis Investigative Site, Los Angeles
A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema
RecruitingPhase 2
- Metropolis Dermatology - DTLA, Los Angeles
A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis
RecruitingPhase 2
- Investigational Site, Los Angeles
A Long Term Extension Study to Evaluate the Safety and Efficacy of Afimkibart (RO7790121) in Participants With Atopic Dermatitis
RecruitingPhase 2
- UCLA Division of Dermatology, Los Angeles
- Dermatology Research Associate, Los Angeles
A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
RecruitingPhase 2
- Metropolis Dermatology, Los Angeles
- Dermatology Research Associates, Los Angeles
- University of California Los Angeles, Los Angeles
A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
RecruitingPhase 2
- Inmagene Site 23, Los Angeles
A Phase 2b Dose-Ranging Study to Evaluate the Efficacy and Safety of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
RecruitingPhase 2
- Enveda Investigative Site, Los Angeles
Evaluate Efficacy and Safety of Repeat Subcutaneous Doses of FB825 in Adults With Moderate-to-Severe Atopic Dermatitis
RecruitingPhase 2
- California Allergy and Asthma Medical Group, Los Angeles
A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis
RecruitingPhase 2
- California Allergy and Asthma Medical Group, Los Angeles
Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
RecruitingObservational study
- Galderma Investigational Site 7099, Los Angeles
Atopic Dermatitis (Eczema) trials in other cities
- New York City, NY13 studies
- Washington, DC11 studies
- San Antonio, TX10 studies
- San Diego, CA10 studies
- Miami, FL9 studies
- Birmingham, AL9 studies
- Dallas, TX8 studies
- Huntington Beach, CA8 studies
- Sacramento, CA8 studies
- Troy, MI8 studies
- Indianapolis, IN7 studies
- Tampa, FL7 studies
Other studies in Los Angeles
- Non-Small Cell Lung Cancer87 studies
- Cancer (all types)74 studies
- Breast Cancer73 studies
- Prostate Cancer61 studies
- Colorectal Cancer59 studies
- Metastatic Cancer57 studies
- Ovarian Cancer50 studies
- Lung Cancer45 studies
- Head and Neck Squamous Cell Carcinoma42 studies
- Pancreatic Cancer35 studies
- Endometrial Cancer34 studies
- Melanoma34 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.